Sort
48,018 grants matching “immunotherapy”
Specific Adoptive Immunotherapy of Myeloid Malignancy
$453,406Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
In vivo efficacy evaluation of novel melanoma actives
$453,399Dmitriy Minond · Nova Southeastern University · R15 · FY2020 · CA
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$453,374Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2015 · CA
Mechanisms of Lymphomagenesis of Skin Resident Gamma Delta T cells
$453,336Jaehyuk Choi · Northwestern University At Chicago · R01 · FY2023 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$453,321Anna Pomes · Indoor Biotechnologies · R01 · FY2011 · AI
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
$453,296Jayachandra B Ramapuram · Auburn University At Auburn · R15 · FY2023 · EY
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$453,289Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · AI
Characterizing the regulation of PD-1 ligands in head and neck cancer stem cells using an autologous humanized model with T cell education capability
$453,267Antonio Jimeno · University Of Colorado Denver · R01 · FY2019 · CA
Pathogenesis of EBV Infection
$453,231Frederick C. Wang · Brigham And Women'S Hospital · R01 · FY2012 · CA
The Role of Schwann Cells in the Progression of Melanoma
$453,195Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Mutational signature analysis: methods and applications to the clinic
$453,188Peter Park · Harvard Medical School · R01 · FY2022 · CA
Abrogating Nanoparticle-induced Immunosuppression in Tumor Microenvironment
$453,173Ninh La-Beck · Texas Tech University Health Scis Center · R15 · FY2015 · CA
Immunotherapeutic targeting of colon cancer vascularization to achieve long-term protective immunity
$453,079Devin B Lowe · Texas Tech University Health Scis Center · R15 · FY2018 · CA
Cancer Immunology Training Grant
$453,016Kai W Wucherpfennig · Dana-Farber Cancer Inst · T32 · FY2016 · CA
Development of Immunologic therapies against uveitis
$452,999Charles E Egwuagu · National Eye Institute · ZIA · FY2021 · EY
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$452,967Rong Li · George Washington University · R01 · FY2022 · CA
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$452,967Rong Li · George Washington University · R01 · FY2023 · CA
STING-dependent activation of Natural Killer cells by viral and tumor DNA
$452,956David H Raulet · University Of California Berkeley · R01 · FY2024 · AI
STING-dependent activation of Natural Killer cells by viral and tumor DNA
$452,956David H Raulet · University Of California Berkeley · R01 · FY2022 · AI
STING-dependent activation of Natural Killer cells by viral and tumor DNA
$452,956David H Raulet · University Of California Berkeley · R01 · FY2023 · AI
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$452,939Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2020 · CA
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$452,939Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2018 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$452,938Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$452,903Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Nanodelivery platform for antibody drugs targeting NHL
$452,835Masakazu Kamata · University Of Alabama At Birmingham · R01 · FY2022 · CA